Case Reports in Endocrinology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.8 | Q4 | 12.0% | 0.250 | Q4 | 36.6% |
| 2024 | 0.9 | Q4 | 11.9% | 0.274 | Q4 | 42.7% |
| 2023 | 0.9 | Q4 | 17.7% | 0.237 | Q4 | 40.9% |
| 2022 | 1.1 | 17.5% | 0.272 | Q4 | 47.5% | |
| 2021 | — | 27.0% | 0.260 | Q4 | 47.0% | |
| 2020 | — | — | 0.260 | Q3 | 45.6% | |
| 2019 | — | — | 0.297 | Q3 | 52.0% | |
| 2018 | — | — | 0.437 | Q3 | 61.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2090-651X
ISSN
2090-6501
country
GBcoverage
2012-2026